Pharmacotherapeutic interventions for bipolar disorder type II: addressing multiple symptoms and approaches with a particular emphasis on strategies in lower and middle-income countries



Godman, Brian ORCID: 0000-0001-6539-6972, Grobler, Christoffel, Van-De-Lisle, Marianne, Wale, Janney, Barbosa, Wallace Breno, Massele, Amos, Opondo, Philip, Petrova, Guenka, Tachkov, Konstantin, Sefah, Israel
et al (show 16 more authors) (2019) Pharmacotherapeutic interventions for bipolar disorder type II: addressing multiple symptoms and approaches with a particular emphasis on strategies in lower and middle-income countries. EXPERT OPINION ON PHARMACOTHERAPY, 20 (18). pp. 2237-2255.

This is the latest version of this item.

[img] Text
Godman et al - accepted for publication.docx - Author Accepted Manuscript

Download (689kB)

Abstract

<b>Introduction</b>: Appropriately managing mental disorders is a growing priority across countries in view of the impact on morbidity and mortality. This includes patients with bipolar disorders (BD). Management of BD is a concern as this is a complex disease with often misdiagnosis, which is a major issue in lower and middle-income countries (LMICs) with typically a limited number of trained personnel and resources. This needs to be addressed.<b>Areas covered</b>: Medicines are the cornerstone of managing patients with Bipolar II across countries including LMICs. The choice of medicines, especially antipsychotics, is important in LMICs with high rates of diabetes and HIV. However, care is currently compromised in LMICs by issues such as the stigma, cultural beliefs, a limited number of trained professionals and high patient co-payments.<b>Expert opinion</b>: Encouragingly, some LMICs have introduced guidelines for patients with BD; however, this is very variable. Strategies for the future include addressing the lack of national guidelines for patients with BD, improving resources for mental disorders including personnel, improving medicine availability and patients' rights, and monitoring prescribing against agreed guidelines. A number of strategies have been identified to improve the treatment of patients with Bipolar II in LMICs, and will be followed up.

Item Type: Article
Uncontrolled Keywords: Bipolar disorders, bipolar disorder type II, lower, and middle-income countries, health policies, treatment, pharmaceuticals, differential diagnosis
Depositing User: Symplectic Admin
Date Deposited: 22 Oct 2019 14:39
Last Modified: 19 Jan 2023 00:21
DOI: 10.1080/14656566.2019.1684473
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3059070

Available Versions of this Item